Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells

Journal of Neurosurgery

Volumn 102, Issue 4, 2005, Pages 699-705

  Charalambous, Christiana ^a   Hofman, Florence M ^a   Chen, Thomas C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Central nervous system tumor; Endothelium; Glioblastoma multiforme; Migration; Proliferation; Tumor angiogenesis

Indexed keywords

BLOOD CLOTTING FACTOR 8; BROXURIDINE; CD11B ANTIGEN; CD31 ANTIGEN; CELL MARKER; ENDOGLIN; ENDOTHELIN 1; GROWTH FACTOR; KI 67 ANTIGEN; LIPOCORTIN 5; TETRAZOLIUM; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN A;

APOPTOSIS; ARTICLE; BRAIN CELL; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR CELL; BIOSYNTHESIS; BRAIN; BRAIN TUMOR; CELL CULTURE; CELL MOTION; CYTOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

APOPTOSIS; BRAIN; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; IN SITU NICK-END LABELING; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 18744414228     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.102.4.0699     Document Type: Article

References (24)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
2. Balabanov R, Dore-Duffy P: Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 53:637-644, 1998
3. Brat DG, Van Meir EG: Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397-405, 2004
4. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G: Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 17:1159-1161, 2003
5. Davies DC: Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200:639-646, 2002
6. Denekamp J: Vascular endothelium as the vulnerable element in tumours. Acta Radiol Oncol 23:217-225, 1984
7. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME: Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275-282, 1996
8. Glienke J, Schmitt AO, Pilarsky C, Hinzmann B, Weiss B, Rosenthal A, et al: Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem 267:2820-2830, 2000
9. Griffioen AW: Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy. Cancer J 10:249, 1997
10. Griffioen AW, Damen CA, Blijham GH, Groenewegen G: Endoglin/CD 105 may not be an optimal tumor endothelial treatment target. Breast Cancer Res Treat 39:239-242, 1996
11. Hellwig SM, Damen CA, van Adrichem NP, Blijham GH, Groenewegen G, Griffioen AW: Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors. Cancer Lett 120:203-211, 1997
12. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362, 1999
13. Jackson DE: The unfolding tale of PECAM-1. FEBS Lett 540: 7-14, 2003
14. Jensen RL: Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 49:189-196, 1998
15. Kniesel U, Wolburg H: Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 20:57-76, 2000
16. Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369-3376, 2003
17. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, et al: Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100:323-331, 2000
18. Lopes MB: Angiogenesis in brain tumors. Microsc Res Tech 60: 225-230, 2003
19. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, et al: Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53:161-176, 2001
20. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Kaczmarek E, Ponce F, et al: Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 7:2480-2489, 2001
21. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, et al: Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 61:8340-8346, 2001
22. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al: Genes expressed in human tumor endothelium. Science 289:1197-1202, 2000
23. Traweek ST, Kandalaft PL, Mehta P, Battifora H: The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 96:25-31, 1991
24. Wright TJ, Leach L, Shaw PE, Jones P: Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp Cell Res 280:159-168, 2002